No article text was recorded for this version.
therapeutic dose de-escalation
Version 1 of 122 papers30 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China
- Blog: Tetanus in a vaccinated soil expert - a case report
- Blog: Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder
- Blog: What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022
- Blog: B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of China
- Blog: Dose optimization strategy of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib for chronic myeloid leukemia: From clinical trials to real-life settings
- Blog: Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia
- Blog: The effectiveness and safety of ofatumumab for the treatment of pemphigus vulgaris: a cohort study based on a registry database.
- Blog: A derivative of 3-(1,3-diarylallylidene)oxindoles inhibits dextran sulfate sodium-induced colitis in mice
- Blog: Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23
- Blog: Evaluating the use of generalized dynamic weighted ordinary least squares for individualized HIV treatment strategies
- Blog: A Maladaptive Role for EP4 Receptors in Mouse Mesangial Cells
- Blog: A RESECTED CASE OF ADVANCED ESOPHAGEAL CARCINOMA SHOWING A PROMINENT RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH 5-FU AND LEUCOVORIN
- Blog: Global research hotspots and trends of acute rejection after liver transplantation from 1988 to 2022: a bibliometric analysis
- Blog: Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial
- Blog: Efficacy of switching from premixed insulin to insulin glargine regimen in Type 2 diabetes mellitus patients with different islet functions
- Blog: Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi Method
- Blog: Mathematical modelling, selection and hierarchical inference to determine the minimal dose in IFNα therapy against myeloproliferative neoplasms
- Blog: Surgery combined with anlotinib for local control of patients with resectable extremity desmoid fibromatosis: a retrospective study
- Blog: A Retrospective Exploration of Targeted Maintenance Therapy in Advanced Colorectal Cancer: Based on the Background of Chinese Patient Assistance Program
- Blog: Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis
- Blog: Modeling CD4 + T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_therapeutic_dose_de_escalation_271190d0,
title = {therapeutic dose de-escalation},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/therapeutic-dose-de-escalation/rdr_271190d0cd3d4f4992a0e9dc3e7fa8b3},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_therapeutic_dose_de_escalation_271190d0_v1,
title = {therapeutic dose de-escalation},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/therapeutic-dose-de-escalation/rdr_271190d0cd3d4f4992a0e9dc3e7fa8b3/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}